We further investigated the role of SLITRK4 in other cancer types, which suggested that overexpression of SLITRK4 significantly increased the mortality risk of gastrointestinal cancer, including CRC and gastric cancer (Figure 1e). Here, SLITRK4 is linked to gastric cancer.